This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

21 Mar 2012

Wellcome Trust Launches £200M Fund for Biotech Start-ups

The move is expected to direct investments in emerging healthcare technologies, to give small and medium-sized companies the support they require to fulfill their potential.

The Wellcome Trust is creating a £200m fund to make long-term investments in start-up biotechnology businesses in the healthcare and life sciences sectors.


The primary goal is to generate ‘excellent returns’ for the Wellcome Trust, to help it fund further biomedical research, but the new venture will also provide emerging businesses in the healthcare sector with a valuable new source of funding and guidance. This will help them to turn advances in the life sciences into diagnostics and therapies to improve patient care.


Currently operating under the working title Project Sigma, the business will be chaired by Nigel Keen, founder of Deltex Medical, with Martin Murphy, a former partner at MVM Life Science Partners, as chief executive.


Related News